<?xml version="1.0"?><rss version="2.0">
 <channel>
  <title>StreetInsider.com News Articles</title>
  <link>http://www.streetinsider.com</link>
  <description>Latest StreetInsider.com News Articles</description>
  <language>en-us</language>
  <copyright>Copyright 2022, StreetInsider.com</copyright>
  <managingEditor>rss@streetinsider.com (SI RSS)</managingEditor>
  <webMaster>rss@streetinsider.com (SI RSS)</webMaster>
  <lastBuildDate>Thu, 27 May 2021 08:30:00 -0400</lastBuildDate>
  <docs>http://blogs.law.harvard.edu/tech/rss</docs>
  <image>
   <url>http://www.streetinsider.com/images/rss_logo.gif</url>
   <title>StreetInsider.com News Articles</title>
   <link>http://www.streetinsider.com</link>
   <width>143</width>
   <height>28</height>
  </image>
  <skipHours>
   <hour>0</hour>
   <hour>1</hour>
   <hour>2</hour>
   <hour>3</hour>
   <hour>21</hour>
   <hour>22</hour>
   <hour>23</hour>
  </skipHours>
  <skipDays>
   <day>Saturday</day>
   <day>Sunday</day>
  </skipDays>
  <item>
   <title>WisdomTree Announces ETF Share Splits</title>
   <link>http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html</guid>
   <pubDate>Thu, 27 May 2021 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QSY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WETF</category>
   	  </item>
  <item>
   <title>WisdomTree Announces ETF Share Splits</title>
   <link>http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html</guid>
   <pubDate>Thu, 27 May 2021 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QSY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WETF</category>
   	  </item>
  <item>
   <title>WisdomTree Announces ETF Share Splits</title>
   <link>http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/WisdomTree+Announces+ETF+Share+Splits/18484213.html</guid>
   <pubDate>Thu, 27 May 2021 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QSY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WETF</category>
   	  </item>
  <item>
   <title>WisdomTree Announces ETF Share Splits</title>
   <link>http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html</guid>
   <pubDate>Thu, 27 May 2021 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QSY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WETF</category>
   	  </item>
  <item>
   <title>WisdomTree Announces ETF Share Splits</title>
   <link>http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html</guid>
   <pubDate>Thu, 27 May 2021 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QSY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WETF</category>
   	  </item>
  <item>
   <title>WisdomTree Announces ETF Share Splits</title>
   <link>http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/WisdomTree+Announces+ETF+Share+Splits/18484213.html</guid>
   <pubDate>Thu, 27 May 2021 08:30:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">QSY</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">WETF</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</guid>
   <pubDate>Wed, 12 May 2021 09:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31066700</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</guid>
   <pubDate>Wed, 12 May 2021 09:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31066700</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</guid>
   <pubDate>Wed, 12 May 2021 09:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31066700</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Efmody® to China for Use in Adrenal Insufficiency (AI), including Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Efmody%C2%AE+to+China+for+Use+in+Adrenal+Insufficiency+%28AI%29%2C+including+Congenital+Adrenal+Hyperplasia+%28CAH%29/18406684.html</guid>
   <pubDate>Wed, 12 May 2021 09:07:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.31066700</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</guid>
   <pubDate>Wed, 27 Jan 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</guid>
   <pubDate>Wed, 27 Jan 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</guid>
   <pubDate>Wed, 27 Jan 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Citrine Medicine Announces Strategic Partnership to bring Alkindi® to China for Use in Pediatric Congenital Adrenal Hyperplasia (CAH)</title>
   <link>http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/PRNewswire/Citrine+Medicine+Announces+Strategic+Partnership+to+bring+Alkindi%C2%AE+to+China+for+Use+in+Pediatric+Congenital+Adrenal+Hyperplasia+%28CAH%29/17869318.html</guid>
   <pubDate>Wed, 27 Jan 2021 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.60012004</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals (ETON) Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE</title>
   <link>http://www.streetinsider.com/Corporate+News/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:09:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals (ETON) Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE</title>
   <link>http://www.streetinsider.com/Corporate+News/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Corporate+News/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Corporate+News/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:09:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals (ETON) Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE</title>
   <link>http://www.streetinsider.com/FDA/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:09:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals (ETON) Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE</title>
   <link>http://www.streetinsider.com/FDA/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/FDA/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/FDA/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:09:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals (ETON) Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE</title>
   <link>http://www.streetinsider.com/Management+Comments/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:09:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals (ETON) Announces Acquisition of Canadian Rights for ALKINDI SPRINKLE</title>
   <link>http://www.streetinsider.com/Management+Comments/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Management+Comments/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Management+Comments/Eton+Pharmaceuticals+%28ETON%29+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI+SPRINKLE/17822370.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:09:18 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE</title>
   <link>http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE</title>
   <link>http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals Announces Acquisition of Canadian Rights for ALKINDI® SPRINKLE</title>
   <link>http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Globe+Newswire/Eton+Pharmaceuticals+Announces+Acquisition+of+Canadian+Rights+for+ALKINDI%C2%AE+SPRINKLE/17822156.html</guid>
   <pubDate>Thu, 14 Jan 2021 08:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
  <item>
   <title>Eton Pharmaceuticals Announces Acquisition of U.S Marketing Rights to Pediatric Orphan Drug Alkindi® Sprinkle</title>
   <link>http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+U.S+Marketing+Rights+to+Pediatric+Orphan+Drug+Alkindi%C2%AE+Sprinkle/16671310.html</link>
   <description>Visit StreetInsider.com at http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+U.S+Marketing+Rights+to+Pediatric+Orphan+Drug+Alkindi%C2%AE+Sprinkle/16671310.html for the full story.</description>
   <guid isPermaLink="true">http://www.streetinsider.com/Press+Releases/Eton+Pharmaceuticals+Announces+Acquisition+of+U.S+Marketing+Rights+to+Pediatric+Orphan+Drug+Alkindi%C2%AE+Sprinkle/16671310.html</guid>
   <pubDate>Fri, 27 Mar 2020 07:00:00 -0400</pubDate>
      	<category domain="http://rss.financialcontent.com/stocksymbol">A.06822034</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">DNL</category>
   	   	<category domain="http://rss.financialcontent.com/stocksymbol">ETON</category>
   	  </item>
 </channel>
</rss>
